CC BY-NC-ND 4.0 · Journal of Cardiac Critical Care TSS 2020; 04(01): 51-55
DOI: 10.1055/s-0040-1713490
Point of Technique

COVID-19 ECMO Myths Busted

Amita Sharma
1  Department of Cardiac Anaesthesia, CTC, AIIMS, New Delhi, India
,
Sandeep Sharan
1  Department of Cardiac Anaesthesia, CTC, AIIMS, New Delhi, India
,
Poonam Malhotra Kapoor
1  Department of Cardiac Anaesthesia, CTC, AIIMS, New Delhi, India
,
Ujjwal Kumar Chowdhury
2  Department of CTVS, CTC, AIIMS, New Delhi, India
› Author Affiliations
  

Abstract

Literature has proven that COVID-19 patients develop pneumonia. Prognosis of this is poor in case of COVID-19 patients developing the following: low lymphocyte count (< 16%) which gets lower with active COVID-19 infection, sedentary lifestyle, obesity, and uncontrolled diabetes mellitus with no exercise. A lot of dilemmas and myths in this nascent COVID-19 pandemic period exist regarding the use of ECMO. Perplexities such as do we treat the COVID-19 patients on ECMO, as a pulmonary ARDS pneumonia, and/or do we need high PEEP or moderate PEEP, during ECMO for this ARDS; are some common COVID-19 ECMO myths which this short review aims to cover in a question-answer format.



Publication History

Publication Date:
15 June 2020 (online)

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India